Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction

study evaluates senolytic CAR T-cell therapy targeting uPAR-positive cells in aged mice, showing its effectiveness in mitigating age-related metabolic dysfunction and offering a potential long-lasting treatment for aging-associated conditions.

RNS-60 by Revalesio for Acute Ischemic Stroke: Likelihood of Approval

RNS-60 is under clinical development by Revalesio and currently in Phase II for Acute Ischemic Stroke.

June 20, 2024

Diabetes remains fastest-growing medtech market despite ‘some risk’ from new drugs: analysts

Dive Brief: New diabetes medicines could apply “short-lived pressures” to medtech companies by affecting the use of insulin, according to analysts at Mizuho. The development

June 30, 2023

Dexcom CEO talks Stelo sensor launch, OTC strategy

Dexcom CEO Kevin Sayer shared new data on the company’s first over-the-counter glucose sensor at the J.P. Morgan Healthcare Conference on Monday. Stelo, which is

January 15, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.